Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.metabol.2017.06.003PMID 28641789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of PARL-PINK1-Parkin pathway in adipocyte differentiation.

  2017cited by this paper
• Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.

  2017cited by this paper
• The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline

  2016cited by this paper
• Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.

  2016cited by this paper
• Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.

  2016cited by this paper
• PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways.

  2016cited by this paper
• Leptin and Hormones: Energy Homeostasis.

  2016cited by this paper
• Leptin in health and disease: facts and expectations at its twentieth anniversary.

  2015cited by this paper
• Leptin treatment: facts and expectations.

  2015cited by this paper
• Leptin applications in 2015: what have we learned about leptin and obesity?

  2015cited by this paper
• Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities.

  2015cited by this paper
• From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.

  2015cited by this paper
• Leptin in congenital and HIV-associated lipodystrophy.

  2015cited by this paper
• Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through Protein Kinase A

  2014cited by this paper
• The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.

  2014cited by this paper
• Thiazolidinediones in the treatment of HIV/HAART-associated lipodystrophy syndrome.

  2013cited by this paper
• Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

  2013cited by this paper
• Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials.

  2012cited by this paper
• Effects of high-fat diet and regular aerobic exercise on global gene expression in skeletal muscle of C57BL/6 mice.

  2012cited by this paper
• Lipodystrophies: Genetic and Acquired Body Fat Disorders

  2011cited by this paper
• Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.

  2011cited by this paper
• Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.

  2011cited by this paper
• Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

  2011cited by this paper
• Lipodystrophy: pathophysiology and advances in treatment

  2011cited by this paper
• Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet.

  2011cited by this paper
• Adiponectin in non‐alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas

  2011cited by this paper
• Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.

  2011cited by this paper
• Leptin is an effective treatment for hypothalamic amenorrhea

  2011cited by this paper
• The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications.

  2010cited by this paper
• The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease

  2010cited by this paper
• The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease.

  2009cited by this paper
• Leptin Deficiency

  2009cited by this paper
• Leptin in humans: lessons from translational research.

  2009cited by this paper
• Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.

  2007cited by this paper
• A randomized placebo‐controlled trial of metformin for the treatment of HIV lipodystrophy

  2007cited by this paper
• Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.

  2006cited by this paper
• Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa.

  2005cited by this paper
• Recombinant human leptin in women with hypothalamic amenorrhea.

  2004cited by this paper
• Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers

  2004cited by this paper
• Clinical review 159: Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies.

  2003cited by this paper
• Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

  2003cited by this paper
• Leptin-replacement therapy for lipodystrophy.

  2002cited by this paper
• The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

  2001cited by this paper
• Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

  1999cited by this paper

• Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions

  2025cites this paper
• Epidemiological and Clinical Data from the European lipodystrophy (ECLip) registry.

  2025cites this paper
• Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials

  2025cites this paper
• Familial Screening for the Prevention of Rare Diseases: A Focus on Lipodystrophy in Southern Saudi Arabia

  2024cites this paper
• When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD

  2022cites this paper
• Atypical Progeroid Syndrome with Familial Partial Lipodystrophy due to A Missense c.1045 C > T LMNA Mutation: A Case Report and an Innovative Therapeutic Approach

  2022cites this paper
• The effect of underweight on female and male reproduction.

  2020cites this paper
• Lipodystrophies—Disorders of the Fatty Tissue

  2020cites this paper
• GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans.

  2019cites this paper
• Metabolically healthy versus metabolically unhealthy obesity.

  2019cites this paper
• Off-label uses of denosumab in metabolic bone diseases.

  2019cites this paper
• Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.

  2019cites this paper
• Comorbidities and Survival in Patients with Lipodystrophy: An International Chart Review Study.

  2019cites this paper
• Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2

  2019cites this paper
• Juvenile Paget disease.

  2017cites this paper
• Clinical outcome in a series of pediatric patients with congenital generalized lipodystrophies treated with dietary therapy

  2017cites this paper
• Outliers of bone metabolic diseases.

  2017cites this paper